JHIU
TEVA icon

Janus Henderson Investors US’s Teva Pharmaceuticals TEVA Stock Holding History

Janus Henderson Investors US’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.58M Sell
49,113
-4,223,218
-99% -$144M ﹤0.01% 948
2016
Q4 		$155M Sell
4,272,331
-408,129
-9% -$16.3M 0.13% 205
2016
Q3 		$215M Buy
4,680,460
+102,609
+2% +$5.35M 0.18% 159
2016
Q2 		$230M Buy
4,577,851
+568,998
+14% +$30.3M 0.2% 141
2016
Q1 		$215M Buy
4,008,853
+551,079
+16% +$32.3M 0.19% 142
2015
Q4 		$227M Buy
3,457,774
+200,003
+6% +$12.4M 0.19% 133
2015
Q3 		$184M Buy
3,257,771
+815,256
+33% +$52.9M 0.17% 165
2015
Q2 		$144M Sell
2,442,515
-418,657
-15% -$25.8M 0.12% 236
2015
Q1 		$178M Buy
2,861,172
+705,516
+33% +$41M 0.15% 202
2014
Q4 		$124M Sell
2,155,656
-504,635
-19% -$28.1M 0.11% 247
2014
Q3 		$143M Buy
2,660,291
+353,667
+15% +$18.7M 0.13% 214
2014
Q2 		$121M Buy
2,306,624
+546,016
+31% +$27.9M 0.11% 228
2014
Q1 		$93M Buy
1,760,608
+1,319,650
+299% +$61M 0.09% 284
2013
Q4 		$17.7M Buy
440,958
+139,458
+46% +$5.49M 0.02% 560
2013
Q3 		$11.4M Buy
301,500
+25,355
+9% +$989K 0.01% 624
2013
Q2 		$10.8M Buy
+276,145
New +$10.8M 0.01% 604

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Investors US's TEVA Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Teva Pharmaceuticals (TEVA) stake by 99% in Q1 2017, selling an estimated $144M and leaving 49,113 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #948.

Janus Henderson Investors US first reported a position in TEVA in Q2 2013 and has held it in 16 quarters since. The position peaked at $230M in Q2 2016. 687 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Janus Henderson Investors US held 49,113 shares of Teva Pharmaceuticals worth $1.58M as of Q1 2017.
  • Janus Henderson Investors US sold 4,223,218 Teva Pharmaceuticals shares in Q1 2017, an estimated $144M.
  • Teva Pharmaceuticals made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #948 holding.
  • Janus Henderson Investors US first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Teva Pharmaceuticals position peaked at $230M in Q2 2016.
  • 687 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.